These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 2548443)

  • 1. Sputum levels of fluconazole in humans.
    Ebden P; Neill P; Farrow PR
    Antimicrob Agents Chemother; 1989 Jun; 33(6):963-4. PubMed ID: 2548443
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Pharmacokinetic evaluation of fluconazole in healthy volunteers].
    Shiba K; Saito A; Miyahara T
    Jpn J Antibiot; 1989 Jan; 42(1):17-30. PubMed ID: 2540363
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro and in vivo activities of Sch 39304, fluconazole, and amphotericin B against Histoplasma capsulatum.
    Kobayashi GS; Travis SJ; Rinaldi MG; Medoff G
    Antimicrob Agents Chemother; 1990 Apr; 34(4):524-8. PubMed ID: 2344160
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of oral fluconazole in autologous bone marrow transplantation recipients given TBI and high-dose melphalan.
    Milliken S; Powles R; Jones A; Helenglass G
    Transplant Proc; 1989 Feb; 21(1 Pt 3):3067. PubMed ID: 2539685
    [No Abstract]   [Full Text] [Related]  

  • 5. Plasma levels of voriconazole administered via a nasogastric tube to critically ill patients.
    Mohammedi I; Piens MA; Padoin C; Robert D
    Eur J Clin Microbiol Infect Dis; 2005 May; 24(5):358-60. PubMed ID: 15875225
    [No Abstract]   [Full Text] [Related]  

  • 6. Steady state parenteral kinetics of fluconazole in man.
    Foulds G; Wajszczuk C; Weidler DJ; Garg DJ; Gibson P
    Ann N Y Acad Sci; 1988; 544():427-30. PubMed ID: 2850753
    [No Abstract]   [Full Text] [Related]  

  • 7. Pharmacokinetics and short-term safety of etravirine in combination with fluconazole or voriconazole in HIV-negative volunteers.
    Kakuda TN; Van Solingen-Ristea R; Aharchi F; Smedt GD; Witek J; Nijs S; Vyncke V; Hoetelmans RM
    J Clin Pharmacol; 2013 Jan; 53(1):41-50. PubMed ID: 23400742
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of fluconazole in a patient with documented malabsorption of ketoconazole.
    Drew RH; Perfect JR; Gallis HA
    Clin Pharm; 1988 Aug; 7(8):622-3. PubMed ID: 2844468
    [No Abstract]   [Full Text] [Related]  

  • 9. Fungal peritonitis complicating continuous ambulatory peritoneal dialysis: successful treatment with fluconazole, a new orally active antifungal agent.
    Levine J; Bernard DB; Idelson BA; Farnham H; Saunders C; Sugar AM
    Am J Med; 1989 Jun; 86(6 Pt 2):825-7. PubMed ID: 2543221
    [No Abstract]   [Full Text] [Related]  

  • 10. Fluconazole in the treatment of fungal infections associated with AIDS.
    De Wit S; Clumeck N
    Infection; 1989; 17(3):121-3. PubMed ID: 2544531
    [No Abstract]   [Full Text] [Related]  

  • 11. Pharmacokinetics of fluconazole in cerebrospinal fluid and serum in human coccidioidal meningitis.
    Tucker RM; Williams PL; Arathoon EG; Levine BE; Hartstein AI; Hanson LH; Stevens DA
    Antimicrob Agents Chemother; 1988 Mar; 32(3):369-73. PubMed ID: 2835002
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Voriconazole and fluconazole increase the exposure to oral diazepam.
    Saari TI; Laine K; Bertilsson L; Neuvonen PJ; Olkkola KT
    Eur J Clin Pharmacol; 2007 Oct; 63(10):941-9. PubMed ID: 17676319
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Azole antifungal drugs: old and new.
    Dismukes WE
    Ann Intern Med; 1988 Aug; 109(3):177-9. PubMed ID: 2839058
    [No Abstract]   [Full Text] [Related]  

  • 14. Random plasma concentrations of voriconazole decline over time.
    Mulanovich V; Lewis RE; Raad II; Kontoyiannis DP
    J Infect; 2007 Nov; 55(5):e129-30. PubMed ID: 17804077
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Posaconazole Plasma Concentrations on Days Three to Five Predict Steady-State Levels.
    Prattes J; Duettmann W; Hoenigl M
    Antimicrob Agents Chemother; 2016 Sep; 60(9):5595-9. PubMed ID: 27324763
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of fluconazole and SDZ89-485 for therapy of experimental murine coccidioidomycosis.
    Fierer J; Kirkland T; Finley F
    Antimicrob Agents Chemother; 1990 Jan; 34(1):13-6. PubMed ID: 2327748
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cryptococcal meningitis in the acquired immunodeficiency syndrome (AIDS): successful treatment with fluconazole after failure of amphotericin B.
    Byrne WR; Wajszczuk CP
    Ann Intern Med; 1988 Mar; 108(3):384-5. PubMed ID: 2829678
    [No Abstract]   [Full Text] [Related]  

  • 18. [Clinical evaluation of fluconazole in patients with mycotic infection].
    Matsushima T; Ikeda H; Tomizawa S; Nakamura J; Adachi M; Kawanishi M; Tanabe J; Tano Y
    Jpn J Antibiot; 1989 Jan; 42(1):153-63. PubMed ID: 2540361
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic drug monitoring of voriconazole in a child with invasive aspergillosis requiring extracorporeal membrane oxygenation.
    Brüggemann RJ; Antonius T; Heijst Av; Hoogerbrugge PM; Burger DM; Warris A
    Ther Drug Monit; 2008 Dec; 30(6):643-6. PubMed ID: 19057370
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of HIV-related fluconazole-resistant oral candidosis with D0870, a new triazole antifungal.
    Cartledge JD; Denning DW; Dupont B; Clumeck N; De Wit S; Midgley J; Hawkins DA; Gazzard BG
    AIDS; 1998 Mar; 12(4):411-6. PubMed ID: 9520171
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.